Evidence map›Paper›PMID 26000252›Full record

ArticleFrontiers in cellular and infection microbiology2015

Occurrence of bla CTX-M-1, qnrB1 and virulence genes in avian ESBL-producing Escherichia coli isolates from Tunisia.

Hajer Kilani, Mohamed Salah Abbassi, Sana Ferjani, Riadh Mansouri, Senda Sghaier, Rakia Ben Salem, Imen Jaouani, Gtari Douja, Sana Brahim, Salah Hammami and 2 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in cellular and infection microbiology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
1.7field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it, 36 citations in OpenAlex.

  1. Pooled it
  2. Antimicrobial Resistance in SelectedAntibiotics (Basel, Switzerland) · 2025
    Review
  3. Article
  4. Extended Spectrum β-Lactamase-ProducingAntibiotics (Basel, Switzerland) · 2022
    Article
  5. Occurrence of NDM-1 and VIM-2 Co-ProducingDiagnostics (Basel, Switzerland) · 2021
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 1 country.

Hajer KilaniLaboratory of Bacteriological Research, Institut de la Recherche Vétérinaire de Tunis, Université de Tunis El Manar Tunis, Tunisia ; LR99ES09 Laboratoire de Résistance aux Antimicrobiens, Faculté de Médecine de Tunis, Université de Tunis El Manar Tunis, Tunisia.
Mohamed Salah AbbassiLaboratory of Bacteriological Research, Institut de la Recherche Vétérinaire de Tunis, Université de Tunis El Manar Tunis, Tunisia ; LR99ES09 Laboratoire de Résistance aux Antimicrobiens, Faculté de Médecine de Tunis, Université de Tunis El Manar Tunis, Tunisia.
Sana FerjaniLR99ES09 Laboratoire de Résistance aux Antimicrobiens, Faculté de Médecine de Tunis, Université de Tunis El Manar Tunis, Tunisia ; Hôpital Charles Nicolle, Service de Microbiologie Tunis, Tunisia.
Riadh MansouriLaboratory of Bacteriological Research, Institut de la Recherche Vétérinaire de Tunis, Université de Tunis El Manar Tunis, Tunisia ; Regional Animal Health Center for North Africa (RAHC-NA) Tunis, Tunisia.
Senda SghaierLaboratory of Bacteriological Research, Institut de la Recherche Vétérinaire de Tunis, Université de Tunis El Manar Tunis, Tunisia.
Rakia Ben SalemLaboratory of Bacteriological Research, Institut de la Recherche Vétérinaire de Tunis, Université de Tunis El Manar Tunis, Tunisia.
Imen JaouaniLaboratory of Bacteriological Research, Institut de la Recherche Vétérinaire de Tunis, Université de Tunis El Manar Tunis, Tunisia.
Gtari DoujaLaboratory of Bacteriological Research, Institut de la Recherche Vétérinaire de Tunis, Université de Tunis El Manar Tunis, Tunisia.
Sana BrahimLaboratory of Bacteriological Research, Institut de la Recherche Vétérinaire de Tunis, Université de Tunis El Manar Tunis, Tunisia.
Salah HammamiÉcole Nationale de Médecine Vétérinaire de Sidi Thabet Sidi Thabet, Tunisia.
Noureddine Ben ChehidaLaboratory of Bacteriological Research, Institut de la Recherche Vétérinaire de Tunis, Université de Tunis El Manar Tunis, Tunisia.
Ilhem Boutiba-Ben BoubakerLR99ES09 Laboratoire de Résistance aux Antimicrobiens, Faculté de Médecine de Tunis, Université de Tunis El Manar Tunis, Tunisia ; Hôpital Charles Nicolle, Service de Microbiologie Tunis, Tunisia.
Tunis University · TNTunis El Manar University · TNHôpital Charles-Nicolle · TN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Avian ESBL-producing Escherichia coli isolates have been increasingly reported worldwide. Animal to human dissemination, via food chain or direct contact, of these resistant bacteria has been reported. In Tunisia, little is known about avian ESBL- producing E. coli and further studies are needed. Seventeen ESBL-producing Escherichia coli isolates from poultry feces from two farms (Farm 1 and farm 2) in the North of Tunisia have been used in this study. Eleven of these isolates (from farm 1) have the same resistance profile to nalidixic acid, sulfonamides, streptomycin, tetracycline, and norfloxacine (intermediately resistant). Out of the six isolates recovered from farm 2, only one was co-resistant to tetracycline. All isolates, except one, harbored bla CTX-M-1 gene, and one strain co-harbored the bla TEM-1 gene. The genes tetA and tetB were carried, respectively, by 11 and 1 amongst the 12 tetracycline-resistant isolates. Sulfonamides resistance was encoded by sul1, sul2, and sul3 genes in 3, 17, and 5 isolates, respectively. The qnrB1 was detected in nine strains, one of which co-harbored qnrS1 gene. The search for the class 1 and 2 integrons by PCR showed that in farm 1, class 1 and 2 integrons were found in one and ten isolates, respectively. In farm 2, class 1 integron was found in only one isolate, class 2 was not detected. Only one gene cassette arrangement was demonstrated in the variable regions (VR) of the 10 int2-positive isolates: dfrA1- sat2-aadA1. The size of the VR of the class 1 integron was approximately 250 bp in one int1-positive isolate, whereas in the second isolate, no amplification was observed. All isolates of farm 1 belong to the phylogroup A (sub-group A0). However, different types of phylogroups in farm 2 were detected. Each of the phylogroups A1, B22, B23 was detected in one strain, while the D2 phylogroup was found in 3 isolates. The virulence genes iutA, fimH, and traT were detected in 3, 7, and 3 isolates, respectively. Two types of gene combination were detected: iutA+fimH+traT in 3 isolates and iutA+fimH in one isolate. The isolates recovered in farm 1 showed the same profile of PFGE macro-restriction, while isolates of farm 2 presented unrelated PFGE patterns. We conclude that these avian ESBL-producing E. coli isolates show homo- and heterogenic genetic background and that plasmids harboring ESBL genes could be involved in the dissemination of this resistance phenotype.

Indexed as

AnimalsAnti-Bacterial Agentsbeta-LactamasesCluster AnalysisDNA, BacterialDrug Resistance, BacterialEscherichia coliEscherichia coli InfectionsEscherichia coli ProteinsFecesGenotypeIntegronsMicrobial Sensitivity TestsMolecular TypingPlasmidsPolymerase Chain ReactionAnti-Bacterial Agentsbeta-Lactamasesbeta-lactamase TEM-3DNA, BacterialEscherichia coli ProteinsQnr protein, E coliVirulence FactorsblaCTX-M-1clonalityEscherichia coliintegronspoultryqnrB1

Identifiers

PMID26000252
PMCPMC4419849
OpenAlexW1593628608

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.